GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹5,218 Cr | ₹4,247 Cr | ₹6,172 Cr | ₹5,270 Cr | ₹4,611 Cr |
What is the latest Net Current Assets ratio of GLAND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹5,218 Cr |
| Mar2024 | ₹4,247 Cr |
| Mar2023 | ₹6,172 Cr |
| Mar2022 | ₹5,270 Cr |
| Mar2021 | ₹4,611 Cr |
How is Net Current Assets of GLAND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,218 Cr | 22.87 | |
| Mar2024 | ₹4,247 Cr | -31.19 | |
| Mar2023 | ₹6,172 Cr | 17.11 | |
| Mar2022 | ₹5,270 Cr | 14.29 | |
| Mar2021 | ₹4,611 Cr | - | |
Compare Net Current Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹36,055.0 Cr | 0.2% | -6.5% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 0.2% |
-6.5% |
24.3% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses